McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
JAZZ holding history
Jazz Pharmaceuticals plc in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JAZZ overviewAll 13F holders of JAZZFull Q1 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −172−100.0% | Sold out | Holders |
| Q1 2025 | 172 | $21.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 172 | $21.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 172 | $19.2K | <0.1% | +33+23.7% | Added | Holders |
| Q2 2024 | 139 | $14.8K | <0.1% | +19+15.8% | Added | Holders |
| Q1 2024 | 120 | $14.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 120 | $14.8K | <0.1% | −2−1.6% | Reduced | Holders |
| Q3 2023 | 122 | $15.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 122 | $15.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 122 | $17.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 122 | $19.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 122 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 122 | $19.0K | <0.1% | −3−2.4% | Reduced | Holders |
| Q1 2022 | 125 | $19.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 125 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 125 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 125 | $22.0K | <0.1% | +3+2.5% | Added | Holders |
| Q1 2021 | 122 | $20.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.